Literature DB >> 18574228

Menstrual cycle dysfunction associated with neurologic and psychiatric disorders: their treatment in adolescents.

Hadine Joffe1, Frances J Hayes.   

Abstract

Epilepsy, bipolar disorder, and migraines are common disorders that are often associated with disturbances in menstrual function in adolescent girls. Women with untreated epilepsy are more likely to have irregular menstrual cycles than are nonepileptic controls, indicating that the disease itself plays a role in the etiology of these reproductive abnormalities. In addition, many girls with these disorders require chronic maintenance treatment with agents that may perturb the hypothalamic-pituitary-ovarian axis. Valproate is a highly effective antiepileptic drug used widely to treat epilepsy, bipolar disorder, and migraines. Valproate induces features of the polycystic ovary syndrome (PCOS) in approximately 7% of women. Girls with epilepsy, and possibly bipolar disorder, appear particularly susceptible to developing PCOS features on valproate, perhaps on account of the relative immaturity of their hypothalamic-pituitary-ovarian axes. Antipsychotics are highly effective drugs used widely to treat adolescents with bipolar disorder, psychotic disorders, and behavioral disturbances. Some, but not all of the antipsychotic, induce hyperprolactinemia, which may result in oligo- or amenorrhea. Prolonged amenorrhea in association with hyperprolactinemia incurs significant risks for bone health in adolescent girls. Because of the potential reproductive health risks associated with use of specific antiepileptic drugs and selective antipsychotics, these agents are vital treatments for adolescents with severe illnesses. Use of these agents should be considered and weighed against the risk of using alternative agents, which have their own side effects, or not treating these serious neurologic and psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18574228      PMCID: PMC3773702          DOI: 10.1196/annals.1429.030

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  89 in total

Review 1.  Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents.

Authors:  Christoph U Correll; Harold E Carlson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-07       Impact factor: 8.829

2.  The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations.

Authors:  A M Crawford; C M Beasley; G D Tollefson
Journal:  Schizophr Res       Date:  1997-07-25       Impact factor: 4.939

3.  Menstrual dysfunction prior to onset of psychiatric illness is reported more commonly by women with bipolar disorder than by women with unipolar depression and healthy controls.

Authors:  Hadine Joffe; Deborah R Kim; John M Foris; Claudia F Baldassano; Laszlo Gyulai; Cindy H Hwang; Wren L McLaughlin; Gary S Sachs; Michael E Thase; Bernard L Harlow; Lee S Cohen
Journal:  J Clin Psychiatry       Date:  2006-02       Impact factor: 4.384

4.  Reproductive endocrine disorders in women with primary generalized epilepsy.

Authors:  L Bilo; R Meo; C Nappi; L Annunziato; S Striano; A M Colao; B Merola; G A Buscaino
Journal:  Epilepsia       Date:  1988 Sep-Oct       Impact factor: 5.864

5.  Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy.

Authors:  J Rättyä; J Turkka; A J Pakarinen; M Knip; M A Kotila; O Lukkarinen; V V Myllylä; J I Isojärvi
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

6.  Endocrine effects of valproate in adolescent girls with epilepsy.

Authors:  Liat de Vries; Anna Karasik; Zohar Landau; Moshe Phillip; Sara Kiviti; Hadassa Goldberg-Stern
Journal:  Epilepsia       Date:  2007-02-22       Impact factor: 5.864

7.  Influence of valproic acid on the gonadotropin-releasing hormone test in puberty.

Authors:  B Lundberg; A Nergårdh; E M Ritzén; K Samuelsson
Journal:  Acta Paediatr Scand       Date:  1986-09

8.  Effects of development on olanzapine-associated adverse events.

Authors:  Scott W Woods; Andres Martin; Steven G Spector; Thomas H McGlashan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-12       Impact factor: 8.829

9.  Prevalence of epilepsy in Rochester, Minnesota: 1940-1980.

Authors:  W A Hauser; J F Annegers; L T Kurland
Journal:  Epilepsia       Date:  1991 Jul-Aug       Impact factor: 5.864

10.  Switch to quetiapine in antipsychotic agent-related hyperprolactinemia.

Authors:  R Keller; F Mongini
Journal:  Neurol Sci       Date:  2002-12       Impact factor: 3.307

View more
  9 in total

Review 1.  Staging perspectives in neurodevelopmental aspects of neuropsychiatry: agents, phases and ages at expression.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

2.  Depression in women with spontaneous 46, XX primary ovarian insufficiency.

Authors:  Peter J Schmidt; Jamie A Luff; Nazli A Haq; Vien H Vanderhoof; Deloris E Koziol; Karim A Calis; David R Rubinow; Lawrence M Nelson
Journal:  J Clin Endocrinol Metab       Date:  2010-11-03       Impact factor: 5.958

Review 3.  Valproic Acid in Women and Girls of Childbearing Age.

Authors:  Dorothy Gotlib; Rachel Ramaswamy; Jacob E Kurlander; Alana DeRiggi; Michelle Riba
Journal:  Curr Psychiatry Rep       Date:  2017-09       Impact factor: 5.285

Review 4.  Gonadal function and reproductive health in women with human immunodeficiency virus infection.

Authors:  Swaytha Yalamanchi; Adrian Dobs; Ruth M Greenblatt
Journal:  Endocrinol Metab Clin North Am       Date:  2014-09       Impact factor: 4.741

5.  Evaluation of reproductive function in women treated for bipolar disorder compared to healthy controls.

Authors:  Margaret F Reynolds-May; Heather A Kenna; Wendy Marsh; Pascale G Stemmle; Po Wang; Terence A Ketter; Natalie L Rasgon
Journal:  Bipolar Disord       Date:  2013-11-22       Impact factor: 6.744

Review 6.  Is Adjunct Aripiprazole Effective in Treating Hyperprolactinemia Induced by Psychotropic Medication? A Narrative Review.

Authors:  Frank M C Besag; Michael J Vasey; Iffah Salim
Journal:  CNS Drugs       Date:  2021-04-20       Impact factor: 5.749

Review 7.  A neuropsychiatric complication of oligomenorrhea according to iranian traditional medicine.

Authors:  Maryam Yavari; Faezeh Khodabandeh; Mojgan Tansaz; Safoura Rouholamin
Journal:  Iran J Reprod Med       Date:  2014-07

8.  Mental health, psychotropic medication use, and menstrual cycle characteristics.

Authors:  Yael I Nillni; Amelia K Wesselink; Elizabeth E Hatch; Ellen M Mikkelsen; Jaimie L Gradus; Kenneth J Rothman; Lauren A Wise
Journal:  Clin Epidemiol       Date:  2018-08-28       Impact factor: 4.790

9.  Is body mass index associated with irregular menstruation: a questionnaire study?

Authors:  Yunhui Tang; Yan Chen; Hua Feng; Chen Zhu; Mancy Tong; Qi Chen
Journal:  BMC Womens Health       Date:  2020-10-08       Impact factor: 2.809

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.